TLDR: Hexaware Technologies has announced a strategic partnership with agentic AI security firm Abluva. The collaboration aims to provide secure and compliant generative AI solutions for the life sciences sector, addressing the security risks associated with autonomous AI agents in areas like research, clinical trials, and patient data management.
Global IT services provider Hexaware Technologies and AI security innovator Abluva have entered into a strategic partnership to tackle the security challenges of autonomous AI agents within the life sciences industry. This collaboration will merge Hexaware’s extensive domain knowledge with Abluva’s advanced Secure Intelligence Plane to enable life sciences organizations to deploy generative AI (GenAI) in a secure and compliant manner.
The partnership is a direct response to the growing adoption of agentic AI in the life sciences for critical operations such as research, clinical trials, patient data management, and commercial activities. The joint solution will ensure that AI agents function within a secure, governed, and auditable framework, fostering innovation without compromising on security.
Key features of the partnership include:
Real-time Agent Governance: Abluva’s Secure Intelligence Plane will enforce vital controls such as purpose binding, role-based context augmentation, data masking, and tooling control to prevent unauthorized AI agent actions.
Comprehensive Agent Life Cycle Security: The solution will implement security protocols to safeguard sensitive data throughout the entire agent life cycle, from fine-tuning and Retrieval Augmented Generation (RAG) to the prompting stages.
Autonomous Threat Mitigation and Self-Healing: A patent-pending ‘self-healing’ capability from Abluva will allow the system to autonomously detect and react to unexpected or anomalous agent behaviors in real-time, mitigating the risks associated with agent autonomy.
Enhanced Compliance and Privacy for AI: The solution is designed to ensure that all AI agent activities adhere to industry standards like HIPAA and GDPR, as well as internal governance policies, through embedded governance and audit features.
Raj Gondhali, AVP & Head of Clinical Solutions at Hexaware, stated, ‘We are thrilled to partner with Abluva to implement the most secure agentic AI solutions for large sponsors and CROs. This collaboration is pivotal, combining our expertise in global clinical solutions with Abluva’s pioneering agentic security technology to ensure enhanced AI safety, compliance, and operational efficiency as our clients adopt next-generation AI.’
Echoing this sentiment, Raj Darji, CEO at Abluva, said, ‘We are excited to announce our partnership with Hexaware, a global systems integration specialist renowned for its Life Sciences expertise. By integrating our Secure Intelligence Plane with Hexaware’s capabilities, we can deliver sophisticated, real-time governance solutions tailored to secure autonomous AI agents in complex life sciences environments.’
Also Read:
- Aisera and AWS Forge Strategic Alliance to Advance Autonomous AI Adoption
- KPMG and Hippocratic AI Partner to Revolutionize Healthcare with AI Agents Amidst Global Staffing Crisis
This partnership highlights Hexaware’s dedication to next-generation cloud and AI platforms and Abluva’s leadership in research-driven, agentic security innovations. Together, the two companies are set to empower life sciences enterprises to leverage the full potential of GenAI securely and at scale.
